| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $12.36M | $8.22M | $7.69M | $11.07M | $14.10M |
| R&D | $5.95M | $3.25M | $3.48M | $4.84M | $7.35M |
| SG&A | $6.41M | $4.97M | $4.21M | – | – |
| Operating Income | -$12.36M | -$8.22M | -$7.69M | -$11.07M | -$14.10M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$12.47M | -$8.19M | -$7.85M | -$11.37M | -$14.31M |
| EPS (basic) | -0.9000 | -1.2800 | -2.3000 | -9.5000 | – |
| EPS (diluted) | -0.9000 | -1.2800 | -2.3000 | -8.7900 | – |
| Shares (diluted) | $13.81M | $6.38M | $3.41M | $1.20M | – |